Evidence map›Paper›PMID 31451429›Full record

ArticleMolecular metabolism2019

Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation.

Sarah Kassab, Paul Begley, Stephanie J Church, Sanziana M Rotariu, Cleo Chevalier-Riffard, Andrew W Dowsey, Alexander M Phillips, Leo A H Zeef, Ben Grayson, Joanna C Neill and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Avicenna journal of phytomedicine · 2026
    Article
  3. Review
  4. Review
  5. Subchronic effects of HgClFrontiers in toxicology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  10. Review
  11. Effects ofMolecules (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. SIRT1 Mediates HNeurochemical research · 2021
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sarah KassabFaculty of Biology, Medicine and Health, University of Manchester, UK.
Paul BegleyFaculty of Biology, Medicine and Health, University of Manchester, UK.
Stephanie J ChurchFaculty of Biology, Medicine and Health, University of Manchester, UK.
Sanziana M RotariuFaculty of Biology, Medicine and Health, University of Manchester, UK.
Cleo Chevalier-RiffardFaculty of Biology, Medicine and Health, University of Manchester, UK.
Andrew W DowseyDepartment of Population Health Sciences and Bristol Veterinary School, Faculty of Health Sciences, University of Bristol, Bristol, BS8 2BN, UK.
Alexander M PhillipsDepartment of Electrical Engineering and Electronics, University of Liverpool, UK.
Leo A H ZeefFaculty of Biology, Medicine and Health, University of Manchester, UK.
Ben GraysonFaculty of Biology, Medicine and Health, University of Manchester, UK.
Joanna C NeillFaculty of Biology, Medicine and Health, University of Manchester, UK.
Garth J S CooperFaculty of Biology, Medicine and Health, University of Manchester, UK; School of Biological Sciences, University of Auckland, New Zealand.
Richard D UnwinFaculty of Biology, Medicine and Health, University of Manchester, UK.
Natalie J GardinerFaculty of Biology, Medicine and Health, University of Manchester, UK. Electronic address: natalie.gardiner@manchester.ac.uk.
University of Manchester · GBManchester Academic Health Science Centre · GBUniversity of Auckland · NZUniversity of Bristol · GBUniversity of Liverpool · GB

Funding

Medical Research Council MR/K501311/1Medical Research Council MR/L011093/1Medical Research Council MR/N028457/1
6 · The paper itself

Abstract

objectiveThe impact of diabetes mellitus on the central nervous system is less widely studied than in the peripheral nervous system, but there is increasing evidence that it elevates the risk of developing cognitive deficits. The aim of this study was to characterize the impact of experimental diabetes on the proteome and metabolome of the hippocampus. We tested the hypothesis that the vitamin B6 isoform pyridoxamine is protective against functional and molecular changes in diabetes.

methodsWe tested recognition memory using the novel object recognition (NOR) test in streptozotocin (STZ)-induced diabetic, age-matched control, and pyridoxamine- or insulin-treated diabetic male Wistar rats. Comprehensive untargeted metabolomic and proteomic analyses, using gas chromatography-mass spectrometry and iTRAQ-enabled protein quantitation respectively, were utilized to characterize the molecular changes in the hippocampus in diabetes.

resultsWe demonstrated diabetes-specific, long-term (but not short-term) recognition memory impairment and that this deficit was prevented by insulin or pyridoxamine treatment. Metabolomic analysis showed diabetes-associated changes in 13/82 identified metabolites including polyol pathway intermediates glucose (9.2-fold), fructose (4.9-fold) and sorbitol (5.2-fold). We identified and quantified 4807 hippocampal proteins; 806 were significantly altered in diabetes. Pathway analysis revealed significant alterations in cytoskeletal components associated with synaptic plasticity, glutamatergic signaling, oxidative stress, DNA damage and FXR/RXR activation pathways in the diabetic rat hippocampus.

conclusionsOur data indicate a protective effect of pyridoxamine against diabetes-induced cognitive deficits, and our comprehensive 'omics datasets provide insight into the pathogenesis of cognitive dysfunction enabling development of further mechanistic and therapeutic studies.

Indexed as

AnimalsCognitive DysfunctionDiabetes Mellitus, ExperimentalHypoglycemic AgentsMalePyridoxamineRatsRats, WistarRecognition, PsychologyStreptozocinHypoglycemic AgentsPyridoxaminepyridoxamine dihydrochlorideStreptozocinCognitive declineDiabetesMetabolomicsProteomicsPyridoxamineSynaptic plasticity

Identifiers

PMID31451429
PMCPMC6822151
OpenAlexW2965125608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.